Methylene blue (USP pharmaceutical grade)
Methylene Blue (USP Pharmaceutical Grade) · also known as Methylene blue, Methylene blue, USP-grade methylene blue, Methylthioninium Chloride
Methylene blue is a potent MAO-A inhibitor, and in isolated mitochondrial systems it can transfer electrons. Its ability to bypass mitochondrial complexes and improve cognition has not been confirmed in humans. Combining it with serotonergic drugs can cause serious adverse reactions.
Clinical uses and human evidence
Age-related cognitive decline
Studies (2)
- Wischik 2015 · J Alzheimers Dis · RCT · n=321 — Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease
- Gauthier 2016 · Lancet · RCT · n=891 — Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Memory
Attention and focus
Mechanisms of action
Monoamine neurotransmitter balance (dopamine, norepinephrine, 5-HT)
Methylene blue is a potent MAO-A inhibitor, with a Ki of about 27 nmol/L in purified enzyme experiments. Increases in synaptic neurotransmitters in humans have not been measured directly, but drug labeling already warns of serotonin syndrome risk when it is combined with serotonergic drugs.
Mitochondrial electron transport chain carriers and oxidative phosphorylation coupling
In isolated mitochondrial systems, methylene blue can transfer electrons, and in theory it could sustain electron transport when a complex is blocked. However, some studies have not reproduced bypass rescue after complex III is blocked. Whether oral dosing produces the same bypass effect in humans is unresolved.
Cholinergic neurotransmission (ACh precursor supply and AChE inhibition)
In vitro, methylene blue can inhibit cholinesterase and bind muscarinic receptors. These results come from ex vivo experiments. There is no evidence that usual oral doses raise acetylcholine in the human hippocampus or improve memory.
Safety and drug interactions
Serotonin excess risk
A potent MAO-A inhibitor that slows serotonin breakdown. Each of these raises serotonin levels in the brain. Taking two or more together carries a risk of serotonin syndrome, which causes agitation, sweating, a fast heartbeat, muscle twitching and fever. In severe cases it can be life-threatening.
With SSRIs, SNRIs and other serotonergic drugs Do not combine
Combining methylene blue with this class of drugs can cause severe serotonin syndrome. Fatal cases have been reported, so the two must never be combined.
With MAO inhibitors Do not combine
Methylene blue is itself an MAO inhibitor, so combining it with another MAOI can cause fatal serotonin syndrome.
With Isoniazid High risk
Isoniazid has some monoamine oxidase inhibitory activity, and combining it with methylene blue may increase the risk of serotonin syndrome. Do not take methylene blue without medical advice while you are on isoniazid.